Another vital interventional factor is that the reported CAD patients displayed higher circulating levels of sPD-1 or sPD-L1 in their blood, signifying their hindrance in subsiding the inflammatory processes that are assisted by membrane-bound PD-1/PD-L1 interactions. This evidence concerns the gene CD274 and coronary artery disorder.